Poor glycaemic control caused by insulin induced lipohypertrophy.
Chowdhury
Tahseen A
TA
Mile End Diabetes Centre, The Royal London Hospital, London E1 4DG. Tahseen.Chowdhury@bartsandthelondon.nhs.uk
Escudier
Valerie
V
D000273:Adipose Tissue / Q000473:pathology; D000328:Adult; D001786:Blood Glucose / Q000378:metabolism; D003922:Diabetes Mellitus, Type 1 / Q000097:blood / Q000188:drug therapy*; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006984:Hypertrophy / Q000139:chemically induced; D007003:Hypoglycemia / Q000139:chemically induced*; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D007328:Insulin / Q000009:adverse effects*; D008875:Middle Aged; D040521:Subcutaneous Tissue / Q000473:pathology
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin